Skip to Content


We have collaborated with a variety of government and industry organizations in order to develop innovative vaccines. Some of which are listed below:

BARDA - Biomedical Advanced Research and Development Authority

Altimmune was awarded a contract valued at up to $21.7 million by the U.S. Biomedical Advance Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services for the research and development of our NasoShield anthrax vaccine through the non-clinical assessment of efficicacy, bio-distribution and toxicity, manufacturing process and development as required for IND application, regulatory review, and development of a Phase 1 dose ranging protocol to assess safety and immunogenicty.